Nonacus Limited in Birmingham, B32 1AF

Description

Data updated on: 01-11-2023

Nonacus started its business in the year 2015 as a Private Limited Company under the ID 09590278. The company has been functioning for 9 years and the present status is active. This firm's head office is registered in Birmingham at Unit 5 Quinton Business Park 11 Ridgeway. Anyone could also find this business utilizing the area code, B32 1AF. The firm's principal business activity number is 72110 and their NACE code stands for Research and experimental development on biotechnology. The latest annual accounts cover the period up to 2022-12-31 and the most recent confirmation statement was filed on 2023-06-30.

The following company owes its accomplishments and unending development to a group of three directors, who are Graham S., Christopher S. and Lee S., who have been managing the firm for 8 years.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2016-05-31	2017-05-31	2018-05-31	2019-05-31	2019-12-31	2020-12-31	2021-12-31
Currency
Net Worth	-2 930	-90 695

Balance Sheet
Cash Bank On Hand					284 451	1 974 466	30 620 747
Current Assets	149 161	48 393	66 871	292 697	413 419	3 530 892	35 014 408
Debtors					50 821	1 318 669	3 408 210
Net Assets Liabilities		90 695	242 282	100 764	271 339	2 334 673	25 186 089
Other Debtors					16 580	36 786
Property Plant Equipment					104 632	840 207	2 896 148
Total Inventories					78 147	237 756	985 451
Cash Bank In Hand	149 161
Net Assets Liabilities Including Pension Asset Liability	-2 930	-90 695

Capital & Reserves
Called Up Share Capital	125
Profit Loss Account Reserve	-3 055
Shareholder Funds	-2 930	-90 695

Other Financial Data
Accrued Liabilities Deferred Income						9 355	16 647
Accumulated Depreciation Impairment Property Plant Equipment					22 999	90 014	475 070
Additions Other Than Through Business Combinations Property Plant Equipment							2 440 997
Administrative Expenses						1 634 596	7 364 083
Amounts Owed By Group Undertakings						34 682	99
Average Number Employees During Period				4	9	13	48
Bank Borrowings						50 000
Bank Borrowings Overdrafts						5 833
Comprehensive Income Expense					-79 425	2 063 333	27 351 416
Corporation Tax Payable						100 825	6 022 408
Cost Sales						3 044 321	12 590 501
Creditors		156 704	228 031	486 523	133 939	1 992 260	12 174 201
Current Tax For Period						100 825	6 022 408
Deferred Tax Expense Credit Relating To Origination Reversal Timing Differences							550 268
Depreciation Expense Property Plant Equipment						67 015	385 056
Dividends Paid							4 500 000
Dividends Paid On Shares Interim							4 500 000
Fixed Assets		17 616	21 357	32 943	104 632	840 208	2 896 150
Further Item Interest Expense Component Total Interest Expense						1 130
Further Item Tax Increase Decrease Component Adjusting Items						-85 747	550 269
Gain Loss Due To Foreign Exchange Differences Recognised In Profit Or Loss						-5 913	-4 478
Government Grant Income						73 367
Gross Profit Loss						3 640 685	41 288 196
Income Expense Recognised Directly In Equity					250 000
Increase Decrease In Current Tax From Adjustment For Prior Periods						-85 747
Increase From Depreciation Charge For Year Property Plant Equipment						67 015	385 056
Interest Expense On Bank Overdrafts Bank Loans Similar Borrowings							21
Interest Income On Bank Deposits						85
Interest Payable Similar Charges Finance Costs						1 130	21
Investments						1
Investments Fixed Assets						1	2
Investments In Group Undertakings Participating Interests						1
Investments In Subsidiaries						1	2
Issue Equity Instruments					250 000
Net Current Assets Liabilities	-2 930	-108 311	161 160	174 143	279 480	1 538 631	22 840 207
Operating Profit Loss						2 079 456	33 924 113
Other Creditors					6 541	282 464	153 163
Other Interest Receivable Similar Income Finance Income						85
Other Operating Income Format1						73 367
Other Taxation Social Security Payable					12 590	511 193	3 043 563
Pension Other Post-employment Benefit Costs Other Pension Costs						12 575	43 625
Percentage Class Share Held In Subsidiary							100
Prepayments Accrued Income						2 104	1 382 752
Profit Loss					-79 425	2 063 332	27 351 416
Profit Loss On Ordinary Activities Before Tax						2 078 411	33 924 092
Property Plant Equipment Gross Cost					127 631	930 221	3 371 218
Raw Materials Consumables						237 756	985 451
Social Security Costs						89 248	523 826
Staff Costs Employee Benefits Expense						885 558	4 994 583
Taxation Including Deferred Taxation Balance Sheet Subtotal							550 268
Tax Decrease From Utilisation Tax Losses						63 984
Tax Decrease Increase From Effect Revenue Exempt From Taxation						152 492	498 773
Tax Expense Credit Applicable Tax Rate						394 898	6 445 577
Tax Increase Decrease From Effect Adjustment In Research Development Tax Credit						-90 338
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss						12 741	75 603
Tax Tax Credit On Profit Or Loss On Ordinary Activities						15 078	6 572 676
Total Additions Including From Business Combinations Property Plant Equipment						802 590
Total Assets Less Current Liabilities	-2 930	-90 695	139 803	160 883	384 112	2 378 840	25 736 357
Total Borrowings						44 167
Total Current Tax Expense Credit						15 078	6 022 408
Total Operating Lease Payments						47 903	132 124
Trade Creditors Trade Payables					117 272	1 096 484	2 938 420
Trade Debtors Trade Receivables					34 241	1 281 883	2 025 359
Turnover Revenue						6 685 006	53 878 697
Wages Salaries						783 735	4 427 132
Accrued Liabilities Not Expressed Within Creditors Subtotal					2 464
Creditors Due Within One Year	152 091	156 704
Number Shares Allotted	250 000
Par Value Share	0
Share Capital Allotted Called Up Paid	25

Company staff

Graham S.

Role: Director

Appointed: 24 March 2016

Latest update: 9 February 2024

Christopher S.

Role: Director

Appointed: 14 May 2015

Latest update: 9 February 2024

Lee S.

Role: Director

Appointed: 14 May 2015

Latest update: 9 February 2024

People with significant control

The companies with significant control over this firm are as follows: Advanced Genomics Limited owns over 3/4 of company shares and has 3/4 to full of voting rights. This business can be reached in Birmingham at Quinton Business Park 11 Ridgeway, Quinton, B32 1AF and was registered as a PSC under the reg no 13082367.

Advanced Genomics Limited

Address: Unit 5 Quinton Business Park 11 Ridgeway, Quinton, Birmingham, B32 1AF, England

Legal authority English Law

Legal form Private Limited Company

Country registered England

Place registered Companies House

Registration number 13082367

Notified on 27 June 2023

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

right to manage directors

Christopher S.

Notified on 6 April 2016

Ceased on 27 June 2023

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Lee S.

Notified on 6 April 2016

Ceased on 27 June 2023

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Graham S.

Notified on 6 April 2016

Ceased on 27 June 2023

Nature of control:

substantial control or influence

Accounts Documents

Account next due date	30 September 2024
Account last made up date	31 December 2022
Confirmation statement next due date	14 July 2024
Confirmation statement last made up date	30 June 2023

Annual Accounts 8 February 2017
Start Date For Period Covered By Report	2015-05-14
End Date For Period Covered By Report	2016-05-31
Date Approval Accounts	8 February 2017
Annual Accounts 9 December 2017
Start Date For Period Covered By Report	2016-06-01
End Date For Period Covered By Report	2017-05-31
Date Approval Accounts	9 December 2017
Annual Accounts
Start Date For Period Covered By Report	2017-06-01
End Date For Period Covered By Report	2018-05-31
Annual Accounts
Start Date For Period Covered By Report	2018-06-01
End Date For Period Covered By Report	2019-05-31
Annual Accounts
Start Date For Period Covered By Report	2019-06-01
End Date For Period Covered By Report	2019-12-31
Annual Accounts
Start Date For Period Covered By Report	2020-01-01
End Date For Period Covered By Report	31/12/2020
Annual Accounts
Start Date For Period Covered By Report	2021-01-01
End Date For Period Covered By Report	2021-12-31

Nonacus Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Graham S.

Christopher S.

Lee S.

Kay G.

Christopher S.

People with significant control

Advanced Genomics Limited

Christopher S.

Lee S.

Graham S.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Closest Companies - by postcode